Published in Antimicrob Agents Chemother on March 25, 2016
New developments in anti-malarial target candidate and product profiles. Malar J (2017) 1.50
SC83288 is a clinical development candidate for the treatment of severe malaria. Nat Commun (2017) 1.41
An ultrasensitive NanoLuc-based luminescence system for monitoring Plasmodium berghei throughout its life cycle. Malar J (2016) 0.78
Biological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathway. Parasit Vectors (2016) 0.77
The need to compare: assessing the level of agreement of three high-throughput assays against Plasmodium falciparum mature gametocytes. Sci Rep (2017) 0.75
Muddled mechanisms: recent progress towards antimalarial target identification. F1000Res (2016) 0.75
A novel validated assay to support the discovery of new anti-malarial gametocytocidal agents. Malar J (2016) 0.75
Current therapies and future possibilities for drug development against liver-stage malaria. J Clin Invest (2016) 0.75
Human malaria parasites in continuous culture. Science (1976) 59.70
A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen (1999) 32.67
Pyrethroid resistance in African anopheline mosquitoes: what are the implications for malaria control? Trends Parasitol (2010) 8.80
Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol (2010) 6.28
Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev (2011) 5.15
A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature (2015) 3.51
Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science (2014) 3.41
Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue. Proc Natl Acad Sci U S A (2011) 2.83
Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm (2004) 2.63
Malaria medicines: a glass half full? Nat Rev Drug Discov (2015) 2.53
The open access malaria box: a drug discovery catalyst for neglected diseases. PLoS One (2013) 2.43
Primaquine revisited six decades after its discovery. Eur J Med Chem (2008) 2.43
Designing the next generation of medicines for malaria control and eradication. Malar J (2013) 2.25
Drug resistance. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance. Science (2014) 2.02
Spiroindolone KAE609 for falciparum and vivax malaria. N Engl J Med (2014) 1.99
Evidence for environmental modulation of gametocytogenesis in Plasmodium falciparum in continuous culture. Bull World Health Organ (1979) 1.91
Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence "transmission blocking" assay. PLoS One (2012) 1.55
Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs. Antimicrob Agents Chemother (2013) 1.52
A high-throughput screen targeting malaria transmission stages opens new avenues for drug development. J Infect Dis (2011) 1.49
Identification of inhibitors of Plasmodium falciparum gametocyte development. Malar J (2013) 1.43
Antiapicoplast and gametocytocidal screening to identify the mechanisms of action of compounds within the malaria box. Antimicrob Agents Chemother (2013) 1.25
Chemical signatures and new drug targets for gametocytocidal drug development. Sci Rep (2014) 1.22
Identification of MMV malaria box inhibitors of plasmodium falciparum early-stage gametocytes using a luciferase-based high-throughput assay. Antimicrob Agents Chemother (2013) 1.18
A male and female gametocyte functional viability assay to identify biologically relevant malaria transmission-blocking drugs. Antimicrob Agents Chemother (2014) 1.10
Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum. Nat Commun (2014) 1.09
Malaria eradication: is it possible? Is it worth it? Should we do it? Lancet Glob Health (2013) 1.08
A quantitative high throughput assay for identifying gametocytocidal compounds. Mol Biochem Parasitol (2013) 1.07
Gametocytocidal screen identifies novel chemical classes with Plasmodium falciparum transmission blocking activity. PLoS One (2014) 0.99
Developmentally regulated expression of pfs16, a marker for sexual differentiation of the human malaria parasite Plasmodium falciparum. Mol Biochem Parasitol (1997) 0.98
A flow cytometry-based quantitative drug sensitivity assay for all Plasmodium falciparum gametocyte stages. PLoS One (2014) 0.95
Defining the biology component of the drug discovery strategy for malaria eradication. Trends Parasitol (2014) 0.93
A combination of new screening assays for prioritization of transmission-blocking antimalarials reveals distinct dynamics of marketed and experimental drugs. J Antimicrob Chemother (2015) 0.92
High-Throughput Assay and Discovery of Small Molecules that Interrupt Malaria Transmission. Cell Host Microbe (2015) 0.92
Imaging-based high-throughput screening assay to identify new molecules with transmission-blocking potential against Plasmodium falciparum female gamete formation. Antimicrob Agents Chemother (2015) 0.91
Antimalarial drugs: modes of action and mechanisms of parasite resistance. Future Microbiol (2010) 0.90
A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel Imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers. Antimicrob Agents Chemother (2014) 0.90
Transcriptional profiling defines dynamics of parasite tissue sequestration during malaria infection. Genome Med (2015) 0.90
Multicolor bioluminescence boosts malaria research: quantitative dual-color assay and single-cell imaging in Plasmodium falciparum parasites. Anal Chem (2014) 0.88
A simple and predictive phenotypic High Content Imaging assay for Plasmodium falciparum mature gametocytes to identify malaria transmission blocking compounds. Sci Rep (2015) 0.86
Microbiology. Eliminating malaria. Science (2013) 0.83
Plasmodium falciparum transfected with ultra bright NanoLuc luciferase offers high sensitivity detection for the screening of growth and cellular trafficking inhibitors. PLoS One (2014) 0.82
Identification of MMV malaria box inhibitors of plasmodium falciparum early-stage gametocytes using a luciferase-based high-throughput assay. Antimicrob Agents Chemother (2013) 1.18
KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission. Antimicrob Agents Chemother (2014) 1.14
The Mu subunit of Plasmodium falciparum clathrin-associated adaptor protein 2 modulates in vitro parasite response to artemisinin and quinine. Antimicrob Agents Chemother (2015) 1.05